AGM100 Overview

Introduction to MediPines AGM100

The AGM100 is a non-invasive blood oxygenation and cardiopulmonary assessment platform. It delivers information about blood oxygenation, ventilation, and pulmonary gas exchange efficiency to compress cardiopulmonary diagnostics and care decision time.

The AGM100 provides information that would typically require multiple different invasive tests into one integrated device on the spot. It accomplishes this by providing 12 cardiopulmonary parameters (including the partial pressure of oxygen in the arterial blood (gPaO2), end-tidal carbon dioxide tension (PETCO2), and the alveolar to arterial oxygen gradient (O2 deficit)) within 2 minutes from a patient’s breath.

The AGM100 is a diagnostic support tool to aid in decision support.

Example relevant medical conditions: Cardiorespiratory impairment due to infectious disease (COVID-19, Pneumonia) or common respiratory diseases like COPD exacerbation, respiratory failure, Interstitial Lung Disease, pulmonary embolism, heart failure, etc.

Why Use the AGM100?

Healthcare systems that adopt the AGM100 technology will see increased operational efficiency and better patient outcomes. The AGM100 is 10 times cheaper then competing options on a per test basis and 20 times faster then competing options leading to faster results and reduced time to diagnosis. This increased efficiency comes with highly accurate actionable clinical data that leads to better patient outcomes with lower costs to the healthcare system.

This was made possible due to our patented ability to provide accurate PaO2 (arterial blood oxygen) measurements. Currently, physicians can only get PaO2 by drawing an arterial blood sample from patients, which requires qualified staff, expensive analyzers, and takes hours for the clinician to receive. The AGM100 is the only technology on the market that overcomes these limitations.

The AGM100 utilizes high performance oxygen and carbon dioxide sensors, which allows it to calculate many other clinically crucial measurements, like PETCO2, Oxygen Deficit, and the P/F ratio. All the measurements are displayed simultaneously, which provides a powerful comprehensive view of the patients overall cardiopulmonary status.

This grants the user the ability to rapidly assess their patient’s cardiopulmonary status and quickly determine response to therapy immediately at the bedside. The quick results drastically speed up the clinical decision making process in the hospital.